Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Non-Drug Cancer Trials

Research area

non-drug Pancreatic Cancer trials

We list pancreatic cancer studies that test something other than a medication, biologic or supplement. Examples are a device, a procedure or a behavioral program. At Non-Drug Cancer Trials, we help you see if one of these studies might suit your situation.

Updated

Call (888) 338-7068
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Non-drug pancreatic cancer studies in numbers

non-drug pancreatic cancer studies recruiting in the U.S.
55
states with a study site
20
studies that accept healthy volunteers
5

Source: ClinicalTrials.gov. Data processed .

Find non-drug pancreatic cancer studies by state

These states have the most studies recruiting right now.

Non-drug pancreatic cancer studies recruiting now

As of November 18, 2026, 55 non-drug pancreatic cancer studies are recruiting participants in the United States, according to ClinicalTrials.gov. This site lists only studies that test something other than a medication, biologic or supplement, such as a device, a procedure or a behavioral program, as each study is coded in the registry. This is what they have in common.

What they test

  • other approaches21
  • behavioral approaches such as talk therapy or training16
  • devices13
  • procedures13
  • radiation7

A study can test more than one.

Main purpose

  • treating a condition16
  • supportive care11
  • diagnosis10
  • how care is delivered9

Phase

  • Phase 11
  • Phase 1/21
  • Phase 22
  • Phase 32
  • No phase49

Studies of devices and behavioral approaches have no phase.

Who runs them

  • university, hospital or other50
  • industry4
  • government1

Who they enroll

  • adults (18 to 64)54
  • older adults (65 and over)55

5 also accept healthy volunteers.

These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.

Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 55 studies.

Recently updated non-drug pancreatic cancer studies

The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.

  1. Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

    • No phase
    • Ages 18 to 99
    • All sexes
    Sponsor
    Cedars-Sinai Medical Center
    Recruiting in
    Los Angeles, CA
    Registry record
    NCT04907643 · updated
  2. CREO - Microwave Ablation Feasibility Study

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Banner Health
    Recruiting in
    Gilbert, AZ
    Registry record
    NCT07817147 · updated
  3. Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Fox Chase Cancer Center
    Recruiting in
    Philadelphia, PA
    Registry record
    NCT06984562 · updated
  4. Reach and Engagement of GENetic Education, Risk Assessment, and TEsting Feasibility Trial

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Brigham and Women's Hospital
    Recruiting in
    Boston, MA
    Registry record
    NCT07787156 · updated
  5. Disposable Perfusion Phantom for Accurate DCE (Dynamic Contrast Enhanced)-MRI Measurement of Pancreatic Cancer Therapy Response

    • No phase
    • Ages 19 and older
    • All sexes
    Sponsor
    Ohio State University
    Recruiting in
    Columbus, OH · Nashville, TN
    Registry record
    NCT04588025 · updated
  6. EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope

    • No phase
    • Ages 18 to 100
    • All sexes
    Sponsor
    Orlando Health, Inc.
    Recruiting in
    Orlando, FL
    Registry record
    NCT06340620 · updated

Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in the United States on ClinicalTrials.gov.

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and some of the places it is recruiting) exactly as registered. Nothing in a record is reworded. This site lists only studies that test something other than a medication, biologic or supplement, such as a device, a procedure or a behavioral program, as each study is coded in the registry.

Non-Drug Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

What non-drug pancreatic cancer studies look at

Every pancreatic cancer study on this site tests something that is not a medication, biologic or supplement. Examples are a device, a procedure or a behavioral program. Each study sets out to answer one specific question. What you would be asked to do therefore differs from one study to the next.

Whatever a study tests is investigational. Researchers are still learning how well it works and what its risks are. That is why the study exists.

Who may be able to take part

Requirements differ from one pancreatic cancer study to the next. A study may look at how old you are and your past health. It may also consider medications you take now and how the condition affects you. Some studies enroll people without the condition as well.

We do not expect you to judge eligibility alone. That check belongs to the study team, and it happens during a screening visit. Our guide to eligibility and screening explains the process.

What taking part usually involves

  1. A first conversation

    The first step is a conversation. A study coordinator describes the non-drug pancreatic cancer trial in general terms. Your questions are answered then, ahead of every other step.

  2. Informed consent

    Full details come to you in writing from the study team. Known risks are included. Whether to agree is your decision.

  3. Screening

    Screening is made up of health questions and tests. The results show whether this non-drug study suits you. Some people who complete screening do not go on to join.

  4. Study visits

    Joining a non-drug cancer trial means coming to planned visits. Those visits are how the study team follows your health. You remain free to withdraw whenever you wish.

Questions about non-drug pancreatic cancer studies

Do I need a diagnosis to join a study about pancreatic cancer?

This varies by study. A confirmed diagnosis is required for some. In others, you are assessed during screening. The study team will explain which applies to you.

Would I have to change the care I receive now?

Rules about current care differ from one non-drug cancer trial to the next. In some, your existing care carries on. In others, it cannot. Please make no changes to your care by yourself. The study doctor goes through this with you. Before you decide, you are welcome to discuss it with your own doctor too.

Is there a cost to take part?

Participants generally pay nothing for study visits, study tests, or the investigational device, procedure or program being studied. Learn more about costs.

Ask about non-drug pancreatic cancer studies

Asking about a non-drug pancreatic cancer trial starts with a few details about you. Once you send them, a study coordinator will contact you. An enquiry leaves you under no obligation.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Independent information

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 338-7068

or send a short form

How should we reach you?

Call